Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

27 Results Found

Fact Sheets
Public

Fact Sheet: 340B Drug Pricing Program Contract Pharmacy Arrangements

Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for patients in vulnerable communities. 
Case Studies
Public

340B Benefits Patients and Communities: Examples from the Frontlines

The 340B Drug Pricing Program helps ensure access to care for patients and communities most in need. A bipartisan effort by Congress in 1992 designed the program to protect hospitals from rising drug costs — a dynamic that continues to present major challenges today.
Case Studies

Valleywise Health | Arizona

Valleywise Health, with its 340B Program savings, reinvests back into programs that directly benefit patients and the larger community, providing access to high-quality care for all.
Sponsored Executive Dialogues
Member

The Future of Health System-Based Cancer Care

Costly innovative cancer treatments and technologies, organizational alignments and shifting sites of care are changing the way care is delivered.
Case Studies

Monument Health | South Dakota

Monument Health is the largest health care provider in western South Dakota. It is an integral part of the local community, providing a wide array of vital services including behavioral health, oncology and dialysis care.
Case Studies
Public

University of Louisville Health | Kentucky

University of Louisville (UofL) Health is a fully integrated regional academic health system with nine hospitals, a cancer center, an eye institute and nearly 200 clinics serving communities across Kentucky and Southern Indiana.
Letter/Comment
Public

AHA Urges HRSA to Take Immediate Enforcement Action to Block J&J’s Illegal Imposition of 340B Rebate Model

AHA letter regarding the Health Resources and Services Administration’s response to Johnson & Johnson’s (J&J) most recent attempt to undermine the 340B Drug Pricing Program.
Letter/Comment
Public

AHA Letter to CMS on Medicare Transaction Facilitator and Drug Negotiation Program

AHA shares feedback in response to the Centers for Medicare & Medicaid Services’ information collection request (ICR) regarding the Medicare Transaction Facilitator (MTF) and the Medicare drug negotiation program.
Initiatives/Campaigns

340B Hospital Commitment to Good Stewardship Principles

To ensure good stewardship of the 340B program, hospitals participating in the program should structure hospital policies and practices to demonstrate their commitment. That demonstration of commitment includes sharing publicly how 340B savings are used to benefit the community, by, for example reaching more eligible patients and providing more comprehensive services for those in the community.
340B Advocacy Alliance Bulletin
Member

340B Advocacy Alliance Bulletin - March 26, 2024

AHA Submits comments on SUSTAIN 340B draft bill.